Clinical trial
Analysis of T- and B-Cell Subpopulations in Patients With Primary Membranous Nephropathy
NCT05894512 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of T- and B-Cell Subpopulations in Patients With Primary Membranous Nephropathy
- Lead sponsor
- Istanbul University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2023
- Completion date
- February 15, 2026
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
membranous nephropathy, membranous nephropathy - pla2r induced, membranous nephropathy - thsd7a induced